BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax.
Following a period of sustained growth, with revenues increasing from £4m to £12m during BGF’s investment, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH in November 2015 with all shareholders realising a strong return.
Business funding insights
Six financing options for businesses ready to grow
From private equity to crowdfunding, here’s our guide to financing options for established businesses and start-ups
BGF explains: our approach to quoted investments
With more than £500 million of quoted assets under management, BGF is an investor of scale in public markets, with a distinctive approach.